Showing results (2221-2230 of 2,940) with videos related to

Sort By:
Pageof 294
Cancer Investigation|June 17, 1998
In vitro screening model for the detection of agents active against myelogenous leukemiaM Edelstein, T Corbett, F Valeriote
Cancer Investigation|May 13, 2015
Disrupted Balance of MMPs/TIMPs in Gastric Carcinogenesis-Paradoxical Low MMP-2 Expression in Tumor and Stromal Compartments as a Potential Marker of Unfavorable OutcomePiotr Donizy, Julia Rudno-Rudzinska, Maciej Kaczorowski, et al.
Cancer Investigation|May 8, 2015
The Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer TherapyQian Zhan, Yuan Fang, Xiaxing Deng, et al.
Cancer Investigation|January 1, 1989
Illness-related worry among cancer patients: prevalence, severity, and contentM E Stefanek, A Shaw, D DeGeorge, et al.
Cancer Investigation|April 29, 2015
Investigation of epothilone B-induced cell death mechanisms in human epithelial cancer cells -in consideration of combined treatment with ionizing radiationTonja Baumgart, Stephan Kriesen, Oliver Neels, et al.
Cancer Investigation|January 1, 1997
Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancersS E Hiscox, M B Hallett, M C Puntis, et al.
Cancer Investigation|January 1, 1997
Antitumor effect of DT-5461, a lipid A derivative, against human tumor xenografts is mediated by intratumoral production of tumor necrosis factor and affected by host immunosuppressive factors in nude miceE Kumazawa, T Jimbo, T Akimoto, et al.
Cancer Investigation|January 1, 1997
Conformational and electrostatic properties of naphthazarin, juglone, and naphthoquinone: an ab initio theoretical studyA K Bhattacharjee, S S Pundlik, S R Gadre
Cancer Investigation|January 1, 1997
A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with painM Hoffman, J C Xu, C Smith, et al.
Cancer Investigation|February 25, 1998
Relation of free PSA/total PSA in serum for differentiating between patients with prostatic cancer and benign hyperplasia of the prostate: which cutoff should be used?M Lein, C Stephan, K Jung, et al.
Pageof 294